Harbor Health Care UCITS ETF Accum Shs -A- USDHarbor Health Care UCITS ETF Accum Shs -A- USDHarbor Health Care UCITS ETF Accum Shs -A- USD

Harbor Health Care UCITS ETF Accum Shs -A- USD

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪11.15 M‬EUR
Fund flows (1Y)
‪−1.96 M‬EUR
Dividend yield (indicated)
Discount/Premium to NAV
−1.2%
Shares outstanding
‪1.53 M‬
Expense ratio
0.59%

About Harbor Health Care UCITS ETF Accum Shs -A- USD


Issuer
HANetf Holdings Ltd.
Brand
HANetf
Home page
Inception date
Apr 4, 2019
Index tracked
Indxx Advanced Life Sciences & Smart Healthcare Thematic Index
Replication method
Physical
Management style
Passive
Dividend treatment
Capitalizes
Primary advisor
HANetf Management Ltd.
ISIN
IE00BJQTJ848
HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF (WELL) is a UCITS compliance ETF domiciled in Ireland.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Broad-based
Strategy
Vanilla
Geography
Global
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of September 30, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Health Services
Stocks97.79%
Health Technology75.95%
Health Services14.08%
Commercial Services3.89%
Finance2.03%
Distribution Services1.85%
Bonds, Cash & Other2.21%
Cash2.21%
Stock breakdown by region
79%20%
North America79.32%
Europe20.68%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows



Frequently Asked Questions


W311 invests in stocks. The fund's major sectors are Health Technology, with 75.95% stocks, and Health Services, with 14.08% of the basket. The assets are mostly located in the North America region.
W311 top holdings are Ascendis Pharma A/S Sponsored ADR and Eli Lilly and Company, occupying 9.50% and 8.88% of the portfolio correspondingly.
W311 assets under management is ‪11.15 M‬ EUR. It's risen 19.46% over the last month.
W311 fund flows account for ‪65.01 K‬ EUR (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, W311 doesn't pay dividends to its holders.
W311 shares are issued by HANetf Holdings Ltd. under the brand HANetf. The ETF was launched on Apr 4, 2019, and its management style is Passive.
W311 expense ratio is 0.59% meaning you'd have to pay 0.59% of your investment to help manage the fund.
W311 follows the Indxx Advanced Life Sciences & Smart Healthcare Thematic Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
W311 invests in stocks.
W311 price has risen by 3.23% over the last month, and its yearly performance shows a −3.54% decrease. See more dynamics on W311 price chart.
NAV returns, another gauge of an ETF dynamics, showed a 9.21% increase in three-month performance and has decreased by −4.17% in a year.
W311 trades at a premium (0.73%) meaning the ETF is trading at a higher price than the calculated NAV.